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Abstract: Transgenerational immune priming (TGIP) is an intriguing form of parental care which 
leads to the plastic adjustment of the progeny’s immunity according to parental immune experience. 
Such parental effect has been described in several vertebrate and invertebrate taxa. However, very 
few empirical studies have been conducted from the field, with natural host-parasite systems and 
real ecological settings, especially in invertebrates. We investigated TGIP in wild populations of the 
marine annelid Hediste diversicolor. Females laid eggs in a mud tube and thus shared the local 
microbial threats with the first developmental stages, thus meeting expectations for the evolution 
of TGIP. We evidenced that a maternal bacterial challenge led to the higher antibacterial defense of 
the produced oocytes, with higher efficiency in the case of Gram-positive bacterial challenge, 
pointing out a prevalent role of these bacteria in the evolutionary history of TGIP in this species. 
Underlying mechanisms might involve the antimicrobial peptide hedistin that was detected in the 
cytoplasm of oocytes and whose mRNAs were selectively stored in higher quantity in mature 
oocytes, after a maternal immune challenge. Finally, maternal immune transfer was significantly 
inhibited in females living in polluted areas, suggesting associated costs and the possible trade-off 
with female’s protection. 
Keywords: TGIP; maternal effect; immunity; hedistin; antimicrobial peptide; lysozyme; MPII; 
pollutants; Polychaeta 
 
1. Introduction 
Transgenerational immune priming (TGIP) is an intriguing form of parental care that 
corresponds to a plastic adjustment of the offspring immunity according to parental immune 
experience. Through TGIP, young are thereby better at fighting a pathogen that previously infected 
their parents. This immune priming can be highly beneficial to offspring, contributing to their 
adaptation to the local epidemiological conditions, provided the latter encounter microbial threats 
similar to their parents [1–3]. In invertebrate marine taxa, empirical studies of maternal effects, in 
general, and of maternal TGIP, in particular, are scarce [4]. Yet, these effects may be of first 
importance in the response of marine populations to upcoming changes in the dynamics of infectious 
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diseases due to global warming [5]. Theory predicts that, when it occurs, TGIP should most likely 
benefit the most vulnerable life stages, i.e., the youngest stages, which are usually immunologically 
not fully competent [6]. In marine species, it often corresponds to gametes, which are most often 
released in the ocean before fertilization and are thus directly exposed to environmental microbes. 
Consequently, if TGIP is to evolve in marine invertebrates, it is highly expected to concern gametes, 
so as to maintain successful fertilization despite unhealthy environment [7]. 
In vertebrates, the modalities of TGIP especially rely on a maternal transfer of antibodies 
through yolk or milk, for instance [8]. In invertebrates, which are deprived of such immune effectors, 
modalities appear more diverse, and underpinning mechanisms often remain elusive [2]. Indeed, 
many studies have evidenced that an immune challenge of one or both parents enhances the immune 
performance of the offspring, measured as higher resistance to infection/parasitism or higher 
immune activity [9–16]. However, in most cases, so many processes occur between the stage of the 
manipulation (parent immune challenge) and the endpoint measure (immune efficiency in eggs, 
larvae, or adults produced by the primed parent) that the physiological mechanisms underlying TGIP 
cannot be properly evidenced. Among possible mechanisms recently uncovered, mothers can 
directly transfer bacterial constituents to their eggs; this confers no protection to gametes but could 
serve as immune elicitors in the zygote and developing young [17–19]. Mothers may also transfer to 
their oocytes active immune effectors (e.g., antimicrobial peptides (AMP), proteins with bactericidal 
properties, pathogen recognition receptors), or their mRNA precursors [15,20,21]. Finally, mothers, 
as well as fathers, may transfer epigenetic factors (methylation marks, regulatory non-coding RNA) 
through their gametes, thereby influencing more durably the immunity of their offspring in relation 
to their own immune experience [3,22,23]. Note that very few of the studies that have so far 
accumulated knowledge over TGIP modalities in invertebrates have addressed it in wild populations 
and experimentally investigated TGIP in natural host-parasite systems, which means that many 
results need field validation [3]. Moreover, the real comprehension of the occurrence of TGIP and its 
importance in an individual lifetime requires to take into account the ecological settings really 
experienced. In particular, since TGIP may come at some costs for parents as for offspring, it is highly 
probable that its occurrence and intensity depend on the local context. In particular, active immune 
factors transferred to oocytes directly derive from maternal immunity, and thus represent a direct 
cost to her [24–27]. Maternal immune investment is thus expected to show some degree of plasticity 
in relation to the environmental conditions experienced by the mother [28,29]. In some circumstances, 
she may have to manage trade-offs with other functions and, especially, with her immunity in order 
to preserve her reproductive value [27]. 
In the present study, we studied the occurrence and modalities of maternal immune transfer to 
oocytes in the ragworm Hediste diversicolor, a gonochoric species quite tolerant of pollution [30]. Its 
semelparous reproductive strategy and the female’s habit of laying her eggs in her mud tube, thus 
sharing microbial threats with the first developmental stages of her progeny, make this worm species 
a potentially good model to study TGIP. We evidenced an enhancement of the maternal immune 
protection of oocytes after a maternal immune challenge, in a wild population and the context of a 
natural host-parasite system. We brought to light immune mechanisms, in the form of maternal 
transfer of immune components to oocytes, that might contribute to TGIP in this species. We finally 
compared the extent of such a TGIP between females from different environmental backgrounds, 
uncovering a possible trade-off between offspring and female’s immune protection. 
2. Materials and Methods  
2.1. Animal Sampling 
Worms were collected on three shores chosen for their known differences in terms of sediment 
contamination. Sampling sites and pollutants’ load of local sediments are extensively described in 
[31]. Briefly, the site of Authie (AN) is considered as clean and used as a reference site. The site of 
Boulogne-sur-Mer (shortened here as “Boulogne”, BO) is located inside an industrial harbor and is 
characterized by sediments contaminated notably by heavy metals and urban and industrial wastes. 
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Finally, the site of Gravelines (GR) is located in an artificial canal that crosses an urbanized area, and 
sediments there are moderately contaminated compared to Boulogne. We previously demonstrated 
that the worm populations that live in these three sites shared similar neutral genetic background 
[31]. For this study, around sixty worms from each site were hand-collected in April 2014 and brought 
back to the lab together with local water and sediments. Additional sampling of 60 worms was 
collected in Authie in 2017 for the experiment on the selectivity of the transfer. In all cases, we 
specifically selected mature females that could be clearly recognized by the greenish color of their 
tegument [32].  
2.2. Animal Treatment 
Bacterial strains used in immune challenges: We chose two bacterial strains that might be 
plausibly encountered by the worms in their natural habitat: a Gram-positive (gram+) bacteria, 
Bacillus hwajinpoensis, previously isolated by our group from the wall of H. diversicolor’s tube sampled 
in the field (see [31] for details), and a Gram-negative (gram−) bacteria, Vibrio alginolyticus, which is 
an infectious agent widely distributed and responsible of mass-mortality events in marine 
invertebrates. The injection of heat-killed bacterial solutions at 106 CFU/ml was used to mimic 
immune challenges.  
Highlighting maternal immune transfer: A total of 4 batches of 15 females from Authie (clean 
site) were either kept unchallenged (control, C), injected with 10 µl of saline solution (SS), with 10 µl 
of gram+ bacteria (bacillus), or with 10 µl of gram− bacteria (vibrio). After recovery, worms were kept 
under controlled conditions for seven days (photoperiod of 10:14; 12 °C for day time and 9 °C for 
night time; feeding every other day with fish food). 
Experiments on local effects: For each geographic origin, 3 batches of 15 females were either kept 
unchallenged (control, C), injected with 10 µl of saline solution (SS), or injected with 10 µl of gram+ 
bacteria (bacterial challenge, B). This strain was selected since it induced higher immunoreactivity in 
H. diversicolor. After recovery, worms were kept under controlled conditions for seven days. 
2.3. Plasma and Oocyte Sampling 
The coelomic fluid was collected from individual worms previously anesthetized in filtered 
seawater (FSW) with 10% ethanol. The samples were kept on ice for 15 min, leading to a clear 
separation between the dense oocytes, which drop to the bottom of the tube, and the small 
granulocytes (immune cells), which remain free in the supernatant. The latter fraction was carefully 
transferred to a new clean tube and centrifuged for 5 min, 10,000 g at 4 °C to pellet the cells. The cell-
free supernatant was kept as the maternal plasma. The pellet of oocytes was kept for subsequent 
measures of the antibacterial activity or of mRNA quantity. In the first case, the oocyte pellets were 
snap-frozen and kept at −80 °C until further processing. In the second case, each oocyte pellet was 
added with 250 µl of Qiazol (Qiagen, Hilden, Germany), then snap-frozen and kept at −80 °C until 
further processing. When necessary, a small number of oocytes were retrieved from the sample before 
processing to measure the mean diameter of the oocytes with a stereomicroscope Motic (Motic SMZ 
168) and the Images plus 2.0 software (30 oocytes randomly chosen per sample).  
2.4. The Measure of the Antibacterial Activities in Plasma and Oocytes 
The antibacterial activities of plasma and oocyte samples were assessed in 10 µl of each sample, 
using the antibacterial liquid growth assay described in [31]. This assay provided an antibacterial 
score for each sample, obtained as the log2 of the largest dilution at which antibacterial activity was 
detected. The higher the score, the higher the ability to kill the tested bacteria. Results are given as a 
distribution of the antibacterial scores obtained for each studied condition.  
2.5. Detection of Hedistin Peptide and mRNA in Oocyte Samples 
Hedistin is an antimicrobial peptide (AMP) specifically produced by Hediste diversicolor. 
Tasiemski and co-workers evidenced that Natural killer (NK) cells-like constitutively expressed the 
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hedistin gene and released the active peptide in the surrounding cœlomic liquid upon bacterial 
challenge. Active hedistin shows clear antibacterial activity against a broad spectrum of gram+ 
bacteria, and also against the gram− bacteria Vibrio alginolyticus but with less efficiency [33]. Note that 
hedistin gene expression produces an inactive peptide named preprohedistin and that several post-
translational cleavages and modifications are needed to release the active hedistin peptide.  
To detect hedistin peptide in oocyte samples, we carried out a dot-blot experiment with an 
antibody that was specifically raised against the almost complete sequence of hedistin. The 
chemically synthesized immunogenic sequence (LGAWLAGKVAGTVATYAWNRYV) was coupled 
to ovalbumin and used for the immunization procedure of a rabbit (COVALAB, Villeurbanne, 
France). The hedistin antiserum obtained thus detected the active peptide but also the inactive forms 
of the peptide.  
The oocytes of 12 female worms from Authie were collected after a similar process, as explained 
above. For each condition considered (control, saline, bacillus, and vibrio), three females were 
assayed. The raw quantity of proteins per sample was quantified by Bradford assay (Bradford 
Reagent B6916, Sigma-Aldrich, St Louis, MO, USA), then 5 µg of total proteins per sample was 
adjusted in 1.5 µl of sterile water and plotted onto the nitrocellulose membrane (BIO-RAD, Hercules, 
CA, USA). After incubation in blocking buffer (1 h; TBS, 0.1 M–Tween 20, 0.05%–non–fat dry milk, 
2%), the membrane was probed with the rabbit polyclonal anti-hedistin antibody (2 h, 1/500 dilution), 
washed 3 times (TBS, 0.1 M–Tween 20, 0.05%), and then incubated with the peroxidase-conjugated 
anti-rabbit secondary antibody (Abcam, Cambridge, UK; 1/5000; 2 h in TBS-Tween 20, 0.05%). A 
ClarityTM Western ECL Substrate (BIO-RAD) was used for the chemoluminescence visualization of 
the immunolabeling with a Kodak Bio Max light film.  
To assay the histological distribution of preprohedistin mRNA in females, in situ hybridization 
was performed on paraffin-embedded sections of the whole body of unchallenged females. Probes 
used and procedures were similar to those described in [33]. 
2.6. Quantification of mRNA Levels in Oocyte Samples 
Total RNAs were extracted from oocyte samples (n = 4 per site and condition) according to 
Qiazol manufacturer’s instructions. Genomic DNA was retrieved by incubation with DNAse RQ1 
(Promega, Madison, WI, USA) according to the manufacturer’s instructions. Reverse transcription 
was performed on 1 µg of total RNAs with the RevertAid kit (Thermofisher Scientific, Waltham, MA 
USA) using a mix of OligodT (500 ng/µl) and random primers (250 ng/µl). The cDNA obtained was 
then used to measure by qPCR the relative quantity of mRNA of several genes of interest compared 
to that of GAPDH used as a reference gene. Three genes were investigated: hedistin—an AMP; 
lysozyme—an enzyme with antibactericidal activities; and MPII—a metalloprotease involved in the 
detoxification of heavy metals and proved to display antibacterial activity [34]. The sequences of the 
couples of primers used and their efficacy were the following: hedistin (F: 
GATGCAAAGAGGGTGGAAGA; R: TCGATTCCACGCGTATGTAG), E = 2.01; lysozyme (F: 
CCGTATCAGATCAAGGCAATC; R: GATTGGAGCGGTATTTCCAG), E = 2; MPII (F: 
AGGAAACAACGCTGACAACC; R: GCTTCTTCTTGTGGGAATCG), E = 1.98; GAPDH (F: 
CGTATTGGACGTCTGGTCCT; R: TAATCGGCTCCAACAGATCC), E = 1.99. Reactions were run on 
a LightCycler 480 (Roche, Basel, Switzerland), using iTaq Universal SYBR Green Supermix (Bio-Rad, 
Hercules, CA, USA) with the following cycling conditions: 95 °C for 30 s (1 cycle), 95 °C for 15 s, and 
59 °C for 45 s (40 cycles). A single fluorescence read was taken at the end of each 59 °C step, and a 
sample was considered positive if the Cq value was less than 35 cycles. Ratios of expression between 
each gene of interest and GAPDH were calculated using the second derivative method with the Roche 
LightCycler 480 software (v 1.5.1). 
2.7. Statistical Analyses 
Mean oocyte diameters and distributions of antibacterial scores between treatments were 
compared through Kruskal–Wallis tests followed by pairwise comparison of Dunn, using the 
Benjamini–Hochberg adjustment for multiple comparisons to assess which groups were dissimilar 
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from one another (“dunn.test” R package, [35]). For anti-bacillus and anti-vibrio scores measured in 
the same oocyte samples and for anti-bacillus scores measured in oocyte and plasma collected from 
the same females, statistical comparisons were performed through exact Wilcoxon signed-rank tests 
for paired data (“Wilcox.exact” function in exactRankTests R package) (Supplementary material S1).  
To compare gene expression ratios and because we had small sample sizes (n = 4 per site and 
condition), we used permutational analyses using the “lmp” function from the lmPerm package in 
R. Lmp function returns type III sums of squares and implements analysis of variance models, but 
calculates permutation probabilities, making no assumptions about underlying distributions. After 
permutational analyses of variance testing for treatment and site effects and their possible interaction, 
Tukey’s HSD post hoc tests were carried out to infer pairwise differences in gene expression between 
sites and treatments. Global models tested and detailed output of Tukey tests are given in Appendix 
A. 
Interventionary studies involving animals or humans and other studies requiring ethical 
approval must list the authority that provided approval and the corresponding ethical approval code.  
3. Results 
3.1. Antibacterial Activities of Plasma and Oocytes 
To be sure to compare similar items, we first checked that the mean diameter of the oocytes 
produced by females according to their treatment (control, saline-injected, bacteria-injected) was 
similar in each worm population (Kruskal–Wallis tests, p > 0.05). A given volume of oocytes 
homogenate thus corresponded to a similar number of cells for each treatment. 
When injected with bacillus, females showed a clear increase in the anti-bacillus activity of their 
plasma compared to control or saline-injected females (Figure 1a; Table 1). However, females injected 
with vibrio, also showed an increase of the anti-bacillus activity of their plasma, although less 
important. It means that the immune reaction of females, as measurable 7 days after the challenge, 
showed low specificity since females challenged with a gram+ bacteria had similar quantities of anti-
gram+ immune effectors in their plasma as females challenged with a gram− bacteria (Table 2). 
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Figure 1. Levels of antibacterial activities in the plasma (a) and the oocytes (b,c) of female worms 
challenged or not by bacterial injection. Females may be naive (“control”), sham-injected with a saline 
solution (“saline”), or challenged with heat-killed bacteria of the gram+ strain Bacillus hwajinpoensis 
(“bacillus”) or of the gram− strain Vibrio alginolyticus (“vibrio”). For each female, oocyte samples had 
their antibacterial activity estimated against bacillus (b) and vibrio (c). For b and c: control, n = 12; 
saline, n = 11; bacillus, n = 12; vibrio, n = 12. When in the sufficient quantity, the plasma from the 
mother also had its antibacterial activity estimated against bacillus (a: control, n = 12; saline, n = 9; 
bacillus, n = 11; vibrio, n = 6). Within the violin plots, the diamond spot is the marker for the median, 
and the black dots represent raw data. The thickening of the colored plot shows the probability 
density of the data at different values (kernel density estimation). Different letters point out 
significantly different scores between treatments in Dunn’s tests (horizontal comparisons). An 
asterisk rather than a point indicates significantly different scores between paired data (vertical 
comparisons: plasma vs. oocyte anti-bacillus activities or oocyte anti-bacillus vs. anti-vibrio activities). 
Table 1. Kruskal–Wallis (KW) tests. 
Sample type Antibacterial activity tested KW chi-squared df p-value 
Plasma Anti-bacillus 15.35 3 0 * 
Oocytes Anti-bacillus 11.94 3 0.01 * 
Oocytes Anti-vibrio 12.42 3 0.01 * 
Statistically significant differences, detected at p ≤ 0.05, are highlighted with an asterisk (*). df, degree 
of freedom. 
Table 2. Post hoc Dunn tests. 
Comparison z statistic Adjusted p-value 
Plasma anti-bacillus activity 
control vs. saline 0.15 0.44 
control vs. bacillus 3.34 0.0002 * 
control vs. vibrio 2.20 0.028 
saline vs. bacillus 2.96 0.005 * 
saline vs. vibrio −1.96 0.037 
bacillus vs. vibrio 0.58 0.34 
Oocyte anti-bacillus activity 
control vs. saline 0.26 0.47 
control vs. bacillus 3.02 0.007 * 
control vs. vibrio −0.35 0.54 
saline vs. bacillus 2.69 0.011 * 
saline vs. vibrio −0.08 0.47 
bacillus vs. vibrio 2.67 0.008 * 
Oocyte anti-vibrio activity 
control vs. saline 1.41 0.09 
control vs. bacillus 3.05 0.007 * 
control vs. vibrio −2.95 0.005 * 
saline vs. bacillus 1.57 0.12 
saline vs. vibrio −1.47 0.11 
bacillus vs. vibrio 0.10 0.46 
Statistically significant differences, detected at p ≤ 0.025 after Benjamini–Hochberg adjustment for 
multiple comparisons, are highlighted with an asterisk (*). 
By contrast with plasma, the oocytes of gravid females challenged by bacillus showed 
significantly higher anti-bacillus activity than oocytes of gravid females challenged by vibrio (Figure 
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1b; Tables 1 and 2). Females that encountered a gram+ bacteria thus enhanced the immune defense 
of their oocytes selectively against gram+ bacteria. The anti-vibrio response appeared different: 
females challenged with vibrio might produce oocytes with a higher content of anti-vibrio immune 
effectors, but not more than females challenged with bacillus, or even from females injected with 
saline solution (Figure 1c; Tables 1 and 2). Accordingly, when comparing the antibacterial scores 
(anti-bacillus and anti-vibrio) from individual females, we observed that females challenged with 
bacillus produced oocytes with higher anti-bacillus than anti-vibrio activity (Figure 1b,c; exact 
Wilcoxon signed-rank test for paired data, p = 0.002), while females challenged with vibrio produced 
oocytes with similar anti-bacillus and anti-vibrio activities (p = 0.36). TGIP thus seemed more efficient 
towards gram+ bacteria than a gram− bacteria in this species. Interestingly, control females and 
saline-injected females also provided higher anti-bacillus than anti-vibrio immune effectors to their 
oocytes (control: p = 0.02; saline: p = 0.03). On the other hand, no differences were detected between 
the anti-bacillus activities of the oocytes and plasma whatever the treatment of the female (Figure 
1a,b; exact Wilcoxon signed-rank test for paired data, control, p = 0.054; saline, p = 0.19; bacillus, p = 
1; vibrio, p = 0.13).  
Overall, a recent infection of the mother translated into a higher load of antibacterial materials 
stored in the oocytes. However, the specificity of the immune storage into the oocytes appeared 
higher for anti-gram+ defense than for anti-gram− defense. In other words, bacterial infection and, to 
a lesser extent, injury (saline injection) of the mother led to some anti-gram− immune effectors to be 
stored in the oocytes; by contrast, some anti-gram+ immune effectors were stored in the oocytes even 
in control condition, and females specifically enhanced this stock after a challenge with a gram+ 
bacteria. 
3.2. Hedistin Peptide and mRNA in the Maturing Oocyte 
To investigate the relative role of hedistin in the antibacterial activities measured in oocytes, we 
assessed the presence of the peptide in oocyte samples by dot blot. Hedistin peptides targeted by the 
antibody (active hedistin + prohedistin + preprohedistin) were detected in the oocytes of females of 
all conditions (control, saline-injected, bacillus-injected, and vibrio-injected; Figure 2), suggesting that 
the antibacterial activities measured could be at least partly due to the storage of this AMP. However, 
measuring and comparing the size and intensity of the dots with ImageJ gave no significant 
differences between the four treatments (KW chi-squared = 6.08, df = 3, p = 0.11). 
 
Figure 2. Immunodetection of hedistin in oocytes of female worms challenged or not by bacterial 
injection. Females might be naive (“control”), sham-injected with a saline solution (“saline”), or 
challenged with the gram+ strain Bacillus hwajinpoensis (“bacillus”) or the gram− strain Vibrio 
alginolyticus (“vibrio”). For each condition, three females were sampled, and the equivalent quantity 
of their oocyte sample was deposited on the membrane in vertical lines. The presence of hedistin (and 
its precursors) in the samples was detected by an anti-hedistin antibody. Larger and darker dots 
indicate more hedistin (and precursors) in the sample. As a standard, a dilution range of synthetic 
hedistin was plotted at the bottom of the membrane. 
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In addition to the peptidic forms of hedistin—already active or quickly turned active by 
enzymatic cleavage of prohedistin and preprohedistin—we evidenced the presence of other 
precursors of hedistin in the oocytes in the form of mRNAs. FISH labeling with an anti-sense probe 
confirmed the presence of a high quantity of hedistin mRNAs in immune G3 cells (arrowheads, 
Figure 3), but also revealed the storage of hedistin mRNAs in the cytoplasm of the oocytes (arrows, 
Figure 3).  
 
Figure 3. Storage sites of hedistin mRNA in unchallenged females. Transversal slices of naive Hediste 
diversicolor female hybridized with an antisense probe (AS) or with a control sense probe (S) that 
targets the preprohedistin mRNA. The producing granulocytes G3 are specifically labeled in antisense 
conditions (AS, arrowheads), as noticeable by the dark blue labeling of the cell content, together with 
the cytoplasm of the growing oocytes (o) that float freely in the cœlomic cavity (arrows). Round 
shapes inside oocytes correspond to yolk platelets. Scheme adapted from BIODIDAC© Jon 
Houseman. 
We quantified the relative proportion of hedistin mRNAs in oocytes of females collected in 
Authie (clean site) and submitted or not to an immune challenge (bacillus injection). The relative 
quantity of hedistin mRNAs in oocytes was higher for mothers saline-injected or challenged by a 
bacillus (Figure 4a, AN plot). Permutational analyses of variance detected a significant effect of the 
treatment on the hedistin mRNA ratio (Table 3). Moreover, the bacteria-injected group from AN 
stood apart from the control group (Tukey’s HSD post hoc tests, diff = 2.07, p = 0.01), whereas the 
saline-injected group had an in-between response, being statistically different neither from the 
control group (p = 0.51) nor from the bacteria-injected one (p = 0.61). A load of hedistin mRNAs in 
oocytes thus specifically increased in response to a bacterial challenge of the mother by an 
environmental bacterial strain sensitive to hedistin (here, the gram+ B. hwajinpoensis). As a 
comparison, lysozyme and MPII mRNAs were statistically not more abundant in oocytes from 
injected females (Figure 4b,c, AN plot; see Table3 and Appendix A for statistical details). 
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Figure 4. Relative levels of hedistin (a), lysozyme (b), and MPII (metalloprotease II) mRNA (c) in the 
oocytes of females from Authie (AN), Gravelines (GR), and Boulogne (BO) after no treatment (C), 
saline injection (SS), or bacterial injection (B). Authie is a reference site considered as clean; Boulogne 
and Gravelines are polluted shores. Gene expression, measured by RT-qPCR, was estimated by the 
ratio between the specific gene mRNA level and the GAPDH mRNA level used as an internal 
reference. The bacterial injection was made with the Bacillus hwajinpoensis strain. Results are given as 
the mean of four independent measures ± sem for each site and condition. 
Table 3. Permutational analyses of variance for each investigated gene. 
Tested effect df R sum of square R mean square nb of iterations p-value 
Hedistin 
Treatment 2 4.3503 2.1751 5000 0.016 * 
Site 2 6.8946 3.4473 5000 0.0026 * 
treatment:site 4 8.9560 2.2390 5000 0.012 * 
Residuals 27 14.7338 0.5457   
Lysozyme 
Treatment 2 0.002536 0.00126792 51 0.84 
Site 2 0.000438 0.00021904 69 0.72 
treatment:site 4 0.003470 0.00086757 232 0.85 
Residuals 27 0.046668 0.00172844   
MPII 
Treatment 2 18.112 9.0561 5000 0.042 * 
Site 2 4.350 2.1752 260 0.55 
treatment:site 4 12.455 3.1136 680 0.37 
Residuals 27 77.318 2.8636   
Statistically significant differences, detected at p ≤ 0.05, are highlighted with an asterisk (*). MPII, 
metalloprotease II. 
3.3. Influence of the Maternal Environment on Immune Transfer to Oocytes 
Contrarily to Authie, Boulogne and Gravelines have sediments contaminated with heavy metals 
and urban/industrial wastes, more heavily in Boulogne than in Gravelines [31]. Comparing oocytes 
of females from these three sites, we observed no difference in oocyte antibacterial activity for control 
females (Figure 5a; KW chi-squared = 0.41, df = 2, p = 0.81) and saline-injected females (Figure 5b; KW 
chi-squared = 0.31, df = 2, p = 0.86). By contrast, females challenged by bacillus showed different 
oocyte antibacterial activity depending on their geographical origin (Figure 5c; KW chi-squared = 
9.26, df = 2, p = 0.01). Clearly, only females from Authie stored higher quantity of anti-bacillus immune 
effectors in their oocytes after an immune challenge by bacillus (Dunn’s tests: Authie vs. Gravelines, 
z = 2.71, adj p = 0.01; Authie vs. Boulogne, z = 2.51, adj p = 0.009; Gravelines vs. Boulogne, z = −0.07, 
adj p = 0.47). 
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Figure 5. Levels of antibacterial (anti-bacillus) activities in the oocytes of female worms from three 
geographical origins, challenged or not by bacterial injection. Authie is a reference site considered as 
clean; Boulogne and Gravelines are polluted shores. For worms from each site, females might be naive 
(a), sham-injected with a saline solution (b), or challenged with heat-killed bacteria of the gram+ strain 
Bacillus hwajinpoensis (c). Within the violin plots, the diamond spot is the marker for the median, and 
the black dots represent raw data. The thickening of the colored plot shows the probability density of 
the data at different values (kernel density estimation). Numbers indicate sample size, and an asterisk 
points out significantly different scores. 
The specific accumulation of hedistin mRNA in oocytes of immune-challenged females also 
appeared restricted to females from Authie (Figure 4a). Indeed, contrarily to females from Authie, 
females from Gravelines or Boulogne had similar loads of hedistin mRNA in their oocytes whatever 
the treatment and did not accumulate hedistin mRNAs after an immune challenge ((BO: C / SS / B) 
or (GR: C / SS / B): all combinations non-significant in Tukey’s HSD post hoc tests; see Appendix A 
for statistical details). Consequently, bacteria-injected females from Authie presented higher loads of 
hedistin mRNA in their oocytes compared to females from Boulogne (Tukey’s HSD post hoc tests, 
diff = 1.87, p = 0.03) and to a lesser extent from Gravelines (diff = 1.68, p = 0.07). Moreover, 
permutational analyses of variance evidenced a clear site effect for the hedistin mRNA ratio (Table 
3). More precisely, females from Gravelines had oocytes with globally lower loads of hedistin mRNA 
compared to females from Authie (Tukey’s HSD post hoc tests, diff = −1.03, p = 0.005) and also 
Boulogne (diff = −0.77, p = 0.04). An interaction between the site and treatment was also evidenced 
(Table 3). It mainly concerned females from Boulogne compared to that from Authie, with no 
difference for control females (Tukey’s HSD post hoc tests, diff = 0.59, p = 0.9) or saline-injected 
females (diff = 0.48, p = 0.9) but almost twice more hedistin mRNAs loaded in oocytes of bacteria-
injected females from Authie (diff = 1.87, p = 0.03). As a whole, females from Authie stored more 
hedistin mRNA in their oocytes, moderately after saline injection and clearly after bacterial challenge, 
whereas females from both polluted sites appeared unable to make such an immune transfer. Females 
from Boulogne were seemingly less affected, but only for saline-injected females. 
No differences between sites of origin were detected concerning lysozyme mRNA load (Figure 
4b, see Table 3 and Appendix A for statistical details).  
Finally, permutational analyses of variance evidenced a treatment effect for MPII mRNAs 
(Figure 4c, Table 3). However, none of the pairwise differences were significant (see Appendix A for 
statistical details). We could thus conclude a small accumulation of MPII mRNA in oocytes after 
injection, which seems mainly due to the females from Boulogne that might tend to enhance MPII 
loading after bacterial challenge (Tukey’s HSD post hoc tests, diff = −1.70, p = 0.052). 
4. Discussion 
The present study evidenced a maternal transfer of immunity in the annelid Polychaeta Hediste 
diversicolor, a semelparous coastal worm described as tolerant to pollution. We provided here 
evidence that females’ immune experience specifically led to the production of oocytes with a higher 
load of antibacterial defense and of mRNAs coding for antibacterial effectors. Interestingly, anti-
gram+ and anti-gram− responses did not seem equivalent, the former leading to a more effective 
phenomenon of transgenerational immunity. This maternal immune transfer was inhibited in 
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females living in polluted areas. We uncovered here possible costs and trade-offs associated with this 
maternal protection. 
To date, TGIP has been reported in all major invertebrate phyla (insects [10–12,21,36,37], 
crustaceans [1,38,39], molluscs [20,40]), except annelids. The present study filled this gap by 
evidencing TGIP in a marine polychaete. Our study also documented, for the first time, a TGIP 
occurrence in a semelparous species. Zanchi et al. previously suggested that TGIP might be restricted 
to iteroparous species because of the cost it represents for the female [16]. Our results showed, on the 
contrary, that iteroparity was not a prerequisite to the occurrence of TGIP, and suggested that this 
costly maternal investment could evolve if it comes along with a whole set of life-history traits that 
render the benefits of TGIP sufficient to balance the associated costs [2]. In the present case, some 
peculiarity of the life cycle of the species might have promoted TGIP evolution. As an exception 
among the Nereididae, H. diversicolor is characterized by the absence of a planktonic larval stage [41]. 
Its lifecycle is rather holobenthic, with the eggs laid by females in her mud-tube and fertilized in situ 
by males. Larvae then fulfill their development into the female’s tube, all the while protected by their 
mother that will die soon after the larvae have quit the tube [42]. As a consequence, mothers and 
young stages (gametes, embryos, young larvae) share the same environmental microbiota of the 
mud-tube. Maternal exposure to pathogens constitutes thus a good predictor of the likelihood of 
offspring exposure, which may have promoted the evolution of TGIP as a form of transgenerational 
adaptive plasticity [43]. Comparisons with genetically close species that produce dispersing larvae 
(e.g., Platynereis dumerilii) would help corroborate the importance of the predictability of the offspring 
environment in the evolution of TGIP in invertebrates [44,45]. 
Specificity refers to the degree to which the immune system is able to differentiate immune 
elicitors (here bacteria). In invertebrates, the immune response is not as specific as in the vertebrates 
that evolved effectors of very high specificity towards their target (i.e., antibody or lymphocyte 
receptors). However, some degree of specificity, as the ability to discriminate large families of 
pathogens, has been described in many models [46]. In our experiments, females challenged by gram+ 
or gram− bacteria did not respond equivalently in terms of TGIP. A gram+ challenge led to selective 
transgenerational priming, meaning that oocytes from mothers challenged by gram+ bacteria had a 
clear higher defense against gram+ than against gram− bacteria. By contrast, mothers challenged by 
gram− bacteria transferred equivalent anti-gram+ and anti-gram− defenses to their oocytes. It implied 
that the immune system of females was able to discriminate between the two bacterial threats and to 
respond to them differently, loading different quantities and/or type of antimicrobial effectors in their 
growing oocytes. This quite specific detection of pathogens has been suggested to rely on a diverse 
and complex innate immune sensing system in invertebrates [47]. Some degree of specificity in TGIP 
had already been described in other models, such as the insects Tribolium castaneaum [48], Tenebrio 
molitor [49], or the crustacean Daphnia magna [1]. In the case of Hediste, further investigations, 
especially with many more strains of pathogens, are needed to correctly evaluate the degree of 
specificity of the sensing system. 
Interestingly, we observed that control females protected their future eggs with basal levels of 
anti-gram+ molecules but virtually none anti-gram− effectors. They did so while they have very few 
anti-gram+ molecules in their plasma, suggesting an active accumulation of these molecules into the 
oocytes, rather than a passive impregnation of the oocytes from the maternal plasma. Also, saline-
injected females produced oocytes with low levels of anti-gram+ defenses but higher than anti-gram− 
defenses. In all, investment in anti-gram+ protection appeared favored against anti-gram− protection. 
This might be linked to the nature of the bacterial threat: gram+ bacteria are not abundant in seawater 
(<5%) but appear far more present in marine sediments [50], following the example of Bacillus 
hwajinpoensis that was isolated from the wall of Hediste's mud tube [31]. In this case, the worms daily 
coexist with such strains and need permanent constitutive immune processes to control bacteria over-
proliferation and subsequent risk of invasion, as already suggested in other invertebrate models 
[51,52]. On the contrary, opportunistic infections, as those provoked by Vibrio alginolyticus, are rather 
fought by inducible mechanisms [53]. Thus, the higher probability of encountering gram+ bacteria 
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might have favored the evolution of more efficient mechanisms for the detection and transfer of anti-
gram+ effectors, as similarly suggested in the insect T. molitor [25,49].  
We evidenced in the present study that oocytes of primed females showed higher antibacterial 
activities compared to naive females, suggesting that within a short period (7 days here), the oocytes’ 
content in antimicrobial molecules rose, thus providing readily active protection to the gametes that 
would be released in the environment. This protection was possibly due, at least in part, to the storage 
of active hedistin, an AMP with clear anti-gram+ activity, into the oocytes. The dot blot experiment 
proved that hedistin was present in oocytes, but this technique could not distinguish between readily 
active form (hedistin per se) and inactive peptidic precursors (prohedistin and preprohedistin, which 
need to be enzymatically cleaved to produce active hedistin). The two forms might be stored in the 
gametes, conferring two distinct levels of protection: the mature peptide provides immediate 
protection as it is readily active; the (pre)propeptide is inactive but more stable and can thus 
constitute somewhat longer-term protection. In our case, the high content of the whole hedistin in 
oocytes of control females might result from a high content of inactive pro- and preprohedistin but 
few quantities of active hedistin, which would translate into low antibacterial activity, explaining the 
inconsistency between dot blot and antibacterial tests results. The ratio might change in oocytes from 
challenged females via the conversion from inactive to active hedistin in response to the maternal 
immune challenge. We argued that such a mechanism of enzymatic activation of immune effectors is 
a possible newly evidenced mechanism of TGIP. However, more specific dosages would be necessary 
to conclude the specific accumulation of the different forms of hedistin in oocytes following a 
maternal challenge.  
In the same line, we evidenced that hedistin-encoding mRNAs were specifically stored in the 
oocytes after a bacterial challenge of the mother. This storage did not result from a general increase 
in the concentration of immune genes mRNAs in oocytes, as proved by the constant load of lysozyme 
mRNAs, whatever the treatment. Accumulation of maternal mRNAs in oocytes during oogenesis is 
a phenomenon largely described throughout animal kingdom [54]. These mRNAs—either 
synthesized by the oocyte itself or acquired from its neighborhood (e.g., transfer from nurse cells)—
appear remarkably stable (long half-lives) and translationally quiescent (not translated into proteins) 
during oogenesis. Their function is to compensate for the absence of transcription in mature oocytes 
and early zygotes, the genome of which remains silent until the maternal-to-zygotic transition is 
completed (MZT, also referred to as mid-blastula transition) [55]. In the closely related annelid 
Platynereis dumerilii, the MZT has been estimated to occur at 8–10 h post-fertilization (end of 
segmentation, beginning of cell differentiation processes, [56]). Until this point, the embryo is as 
exposed and intrinsically undefended as mature gametes, as it is unable to produce its protective 
molecules from its genome. By storing hedistin mRNAs in their gametes, females thus potentially 
confer protection to the future zygotes and embryos, specifically against pathogens they have a good 
chance to encounter. Through such delayed mechanisms, the influence of the mother’s environment 
on her offspring immunity extends over a period that clearly exceeds the lifetime of proteins she 
could synthesize and transfer. A thorough study, in the basal metazoan Hydra vulgaris, likewise 
dissected the dynamics of a maternal transfer of mRNAs coding an AMP, perculin1a. In this model, 
the maternally derived AMP helped control and shape the symbiotic microbiota that colonized the 
budding individual [57]. Our results on hedistin protein and mRNA thus made this AMP a good 
candidate to be involved in the short-term (as protein and pre-protein) and/or long-term (as mRNA) 
protection of offspring in H. diversicolor. However, it is possible that immune mechanisms other than 
hedistin transfer also contribute to TGIP in this species, notably via the transfer of other antibacterial 
molecules not investigated yet.  
Since immunity is costly, a trade-off between the female’s immunity and the one she transfers 
to her progeny is expected and has been evidenced in other invertebrate models [26,58]. This cost 
could be manifested as reduced fecundity, egg size, or hatching rate. It may also translate into subtler 
effects on females’ survival rate due to negative effects on females’ immunity. No direct cost on egg 
size was evidenced here. By contrast, we revealed a possible hidden cost on females’ survival rate by 
comparing several worm populations exposed to additional environmental stressors. Hediste worms 
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live into a tube dug into the mud; they are thus directly exposed to the pollutants mixed to the 
sediments, leading to possible adverse health outcomes. In this respect, we previously demonstrated 
that Hediste worms that live in the polluted sites of Boulogne and Gravelines had no cost on 
reproduction (no reduction in fecundity) but suffered from several immune disturbances responsible 
of lower immune resistance in front of local pathogens [31]. In the present study, we further 
evidenced that females from the polluted sites were also unable to protect their progeny by immune 
transfer following an immune challenge. This concerned both active antibacterial molecules and 
hedistin mRNAs. In this context, we hypothesized that females from Authie did pay a cost to TGIP 
and that this cost could not be borne by females from Boulogne and Gravelines that already suffered 
from personal immune costs due to their toxic environment. Here, the need for females to survive 
infections is an absolute priority because of their semelparous mode of reproduction: they must 
survive until the end of their unique gametic maturation to expect any fitness gain. It is thus of no 
surprise that females already weakened by their noxious environment should favor their immunity 
to that of their eggs when facing an immune threat that may kill them before reproduction can occur. 
Accordingly, one should expect a time threshold, when oocytes are sufficiently mature to be released, 
from when females’ interests should turn to favor oocyte immune protection as a terminal investment 
before their death.  
In a previous study, we hypothesized that worms from the most polluted site of Boulogne might 
have evolved some tolerance mechanisms to pollution, showing some immune parameters less 
affected and higher survival to experimental infection compared to worms from Gravelines, whose 
contact with pollution is more recent [31]. We wondered if such a tolerance mechanism could be 
expressed in the context of TGIP. We did observe a tendency of females from Boulogne to transfer 
more hedistin mRNA after saline injection. However, when injected with bacteria, females from 
Boulogne appeared as inefficient as those from Gravelines to transfer immune protection to their 
oocytes. Interestingly, these females tended nevertheless to accumulate more MPII mRNA in their 
oocyte after a bacterial challenge, but this result would need to be checked, e.g., with a larger sample 
size. MPII are small cadmium-binding proteins that are produced by a population of immune cells 
of H. diversicolor (G1) and by intestinal cells. They have bactericidal properties but are also proposed 
to be involved in metal detoxification by trapping the excess of essential or non-essential free metal 
ions [59]. If it is confirmed, such maternal transfer may be less costly for tolerant females of Boulogne, 
may help future embryos to better cope with simultaneous multiple stress, despite the inability of the 
mothers to enhance their immune investment in their progeny. 
Overall, many authors agreed to consider that transgenerational plasticity could play a major 
role in species evolution, especially in changing environments [60]. The consequences of life in the 
polluted zone on TGIP efficiency highlighted here suggested that the effect of environmental 
contaminants on local populations might be deeper than previously thought. This deserves further 
investigation to better apprehend future biodiversity in a largely contaminated world. 
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Appendix A 
Global model for hedistin:  
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Hedistin <- lmp (Hed_ratio~treatment*site, data = ovo_ratio, perm = "Exact", seqs = TRUE, center 
= TRUE) 
Tukey multiple comparisons of means: 
$treatment 
 Diff lwr upr p adj 
SS-C 0.70964750 −0.03808968 1.4573847 0.0653320 
B-C 0.76235583 0.01461865 1.5100930 0.0450242 
B-SS 0.05270833 −0.69502885 0.8004455 0.9833114 
$site 
 Diff lwr upr p adj 
GR-AN −1.0318808 −1.77961801 −0.2841437 0.0054865 
BO-AN −0.2644583 −1.01219551 0.4832788 0.6591841 
BO-GR 0.7674225 0.01968532 1.5151597 0.0434061 
$`treatment:site` 
 Diff lwr upr p adj 
SS:AN-C:AN 1.0761000 −0.68144271 2.83364271 0.5184219 
B:AN-C:AN 2.0714000 0.31385729 3.82894271 0.0121837 
C:GR-C:AN −0.2158675 −1.97341021 1.54167521 0.9999670 
SS:GR-C:AN −0.1230500 −1.88059271 1.63449271 0.9999996 
B:GR-C:AN 0.3907750 −1.36676771 2.14831771 0.9974183 
C:BO-C:AN 0.5950250 −1.16251771 2.35256771 0.9623583 
SS:BO-C:AN 1.5550500 −0.20249271 3.31259271 0.1142269 
B:BO-C:AN 0.2040500 −1.55349271 1.96159271 0.9999785 
B:AN-SS:AN 0.9953000 −0.76224271 2.75284271 0.6160078 
C:GR-SS:AN −1.2919675 −3.04951021 0.46557521 0.2878486 
SS:GR-SS:AN −1.1991500 −2.95669271 0.55839271 0.3787317 
B:GR-SS:AN −0.6853250 −2.44286771 1.07221771 0.9190025 
C:BO-SS:AN −-0.4810750 −2.23861771 1.27646771 0.9896603 
SS:BO-SS:AN 0.4789500 −1.27859271 2.23649271 0.9899499 
B:BO-SS:AN −0.8720500 −2.62959271 0.88549271 0.7587755 
C:GR-B:AN −2.2872675 −4.04481021 −0.52972479 0.0043480 
SS:GR-B:AN −2.1944500 −3.95199271 −0.43690729 0.0068008 
B:GR-B:AN −1.6806250 −3.43816771 0.07691771 0.0690933 
C:BO-B:AN −1.4763750 −3.23391771 0.28116771 0.1536504 
SS:BO-B:AN −0.5163500 −2.27389271 1.24119271 0.9838428 
B:BO-B:AN −1.8673500 −3.62489271 −0.10980729 0.0309716 
SS:GR-C:GR 0.0928175 −1.66472521 1.85036021 1.0000000 
B:GR-C:GR 0.6066425 −1.15090021 2.36418521 0.9579946 
C:BO-C:GR 0.8108925 −0.94665021 2.56843521 0.8208871 
SS:BO-C:GR 1.7709175 0.01337479 3.52846021 0.0472151 
B:BO-C:GR 0.4199175 −1.33762521 2.17746021 0.9957792 
B:GR-SS:GR 0.5138250 −1.24371771 2.27136771 0.9843272 
C:BO-SS:GR 0.7180750 −1.03946771 2.47561771 0.8976455 
SS:BO-SS:GR 1.6781000 −0.07944271 3.43564271 0.0698178 
B:BO-SS:GR 0.3271000 −1.43044271 2.08464271 0.9992660 
C:BO-B:GR 0.2042500 −1.55329271 1.96179271 0.9999784 
SS:BO-B:GR 1.1642750 −0.59326771 2.92181771 0.4164727 
B:BO-B:GR −0.1867250 −1.94426771 1.57081771 0.9999892 
SS:BO-C:BO 0.9600250 −0.79751771 2.71756771 0.6583542 
B:BO-C:BO −0.3909750 −2.14851771 1.36656771 0.9974091 
B:BO-SS:BO −1.3510000 −3.10854271 0.40654271 0.2381011 
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Global model for lysozyme:  
Lysozyme <- lmp (Lys_ratio~treatment*site, data = ovo_ratio, perm = "Exact", seqs = TRUE, 
center = TRUE) 
Global model for MPII:  
MPII <- lmp (MPII_ratio~treatment*site, data = ovo_ratio, perm = "Exact", seqs = TRUE, center = 
TRUE) 
Tukey multiple comparisons of means: 
$treatment 
 Diff lwr upr p adj 
SS-C  0.527450 −1.18544805 2.240348 0.7281813 
B-C  1.697383 −0.01551471 3.410281 0.0524671 
B-SS  1.169933 −0.54296471 2.882831 0.2259946 
$site 
 Diff lwr upr p adj 
GR-AN  −0.7890167 −2.501915 0.9238814 0.4971996 
BO-AN  −0.6718000 −2.384698 1.0410980 0.6001904 
BO-GR  0.1172167 −1.595681 1.8301147 0.9842637 
$`treatment:site` 
 Diff lwr upr p adj 
SS:AN-C:AN  1.28700 −2.7391359 5.313136 0.9730468 
B:AN-C:AN  1.22725 −2.7988859 5.253386 0.9797379 
C:GR-C:AN  −0.21955 −4.2456859 3.806586 0.9999999 
SS:GR-C:AN  −0.11375 −4.1398859 3.912386 1.0000000 
B:GR-C:AN  0.48050 −3.5456359 4.506636 0.9999735 
C:BO-C:AN  −0.95185 −4.9779859 3.074286 0.9960699 
SS:BO-C:AN  −0.76230 −4.7884359 3.263836 0.9991693 
B:BO-C:AN  2.21300 −1.8131359 6.239136 0.6511734 
B:AN-SS:AN  −0.05975 −4.0858859 3.966386 1.0000000 
C:GR-SS:AN  −1.50655 −5.5326859 2.519586 0.9346584 
SS:GR-SS:AN  −1.40075 −5.4268859 2.625386 0.9560796 
B:GR-SS:AN  −0.80650 −4.8326359 3.219636 0.9987572 
C:BO-SS:AN  −2.23885 −6.2649859 1.787286 0.6376578 
SS:BO-SS:AN  −2.04930 −6.0754359 1.976836 0.7340597 
B:BO-SS:AN  0.92600 −3.1001359 4.952136 0.9967418 
C:GR-B:AN  −1.44680 −5.4729359 2.579336 0.9474613 
SS:GR-B:AN  −1.34100 −5.3671359 2.685136 0.9657253 
B:GR-B:AN  −0.74675 −4.7728859 3.279386 0.9992840 
C:BO-B:AN  −2.17910 −6.2052359 1.847036 0.6687668 
SS:BO-B:AN  −1.98955 −6.0156859 2.036586 0.7625830 
B:BO-B:AN  0.98575 −3.0403859 5.011886 0.9950245 
SS:GR-C:GR  0.10580 −3.9203359 4.131936 1.0000000 
B:GR-C:GR  0.70005 −3.3260859 4.726186 0.9995522 
C:BO-C:GR  −0.73230 −4.7584359 3.293836 0.9993784 
SS:BO-C:GR  −0.54275 −4.5688859 3.483386 0.9999329 
B:BO-C:GR  2.43255 −1.5935859 6.458686 0.5354583 
B:GR-SS:GR  0.59425 −3.4318859 4.620386 0.9998670 
C:BO-SS:GR  −0.83810 −4.8642359 3.188036 0.9983693 
SS:BO-SS:GR  −0.64855 −4.6746859 3.377586 0.9997448 
B:BO-SS:GR  2.32675 −1.6993859 6.352886 0.5913068 
C:BO-B:GR  −1.43235 −5.4584859 2.593786 0.9502803 
SS:BO-B:GR  −1.24280 −5.2689359 2.783336 0.9781308 
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B:BO-B:GR  1.73250 −2.2936359 5.758636 0.8688633 
SS:BO-C:BO  0.18955 −3.8365859 4.215686 1.0000000 
B:BO-C:BO  3.16485 −0.8612859 7.190986 0.2148936 
B:BO-SS:BO  2.97530 −1.0508359 7.001436 0.2817444 
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